| mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
4e-11 |
| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
3e-09 |
| mRNA |
nelarabine |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
6e-09 |
| mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
6e-08 |
| mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
8e-08 |
| mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
4e-07 |
| mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
4e-07 |
| mRNA |
Docetaxel |
GDSC1000 |
pan-cancer |
AAC |
-0.16 |
5e-07 |
| mRNA |
ML239 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
6e-07 |
| mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
8e-07 |